Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alexander A Farahani"'
Autor:
Dora Dias-Santagata, Rebecca S Heist, Adam Z Bard, Annacarolina F L da Silva, Ibiayi Dagogo-Jack, Valentina Nardi, Lauren L Ritterhouse, Laura M Spring, Nicholas Jessop, Alexander A Farahani, Mari Mino-Kenudson, Jill Allen, Lipika Goyal, Aparna Parikh, Joseph Misdraji, Ganesh Shankar, Justin T Jordan, Maria Martinez-Lage, Matthew Frosch, Timothy Graubert, Amir T Fathi, Gabriela S Hobbs, Robert P Hasserjian, Noopur Raje, Jeremy Abramson, Joel H Schwartz, Ryan J Sullivan, David Miller, Mai P Hoang, Steven Isakoff, Amy Ly, Sara Bouberhan, Jaclyn Watkins, Esther Oliva, Lori Wirth, Peter M Sadow, William Faquin, Gregory M Cote, Yin P Hung, Xin Gao, Chin-Lee Wu, Salil Garg, Miguel Rivera, Long P Le, A John Iafrate, Dejan Juric, Ephraim P Hochberg, Jeffrey Clark, Aditya Bardia, Jochen K Lennerz
Publikováno v:
The oncologist. 27(11)
Background Precision oncology relies on molecular diagnostics, and the value-proposition of modern healthcare networks promises a higher standard of care across partner sites. We present the results of a clinical pilot to standardize precision oncolo
Autor:
Ying-Hsia Chu, Lori J. Wirth, Dora Dias-Santagata, Peter M. Sadow, William C. Faquin, Alexander A. Farahani, Vânia Nosé
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
The discovery of actionable kinase gene rearrangements has revolutionized the therapeutic landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition of targetable cases, correlation between genotypes and tumor behavior,
Autor:
Enrico Moiso, Austin Hendricks, Alexander A. Farahani, Salil Garg, Hetal D. Marble, Stuart S. Levine, Samuel Mildrum, Jochen K. Lennerz
Cancer is a disease manifesting in abrogation of developmental programs, and malignancies are named based on their cell or tissue of origin. However, a systematic atlas of tumor origins is lacking. Here we map the single cell organogenesis of 56 deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7977f45c3e2297b5b7f6499b6882f541
https://doi.org/10.1101/2021.11.15.21266314
https://doi.org/10.1101/2021.11.15.21266314
Autor:
Jakob M.T. Moran, Long P. Le, Valentina Nardi, Josephine Golas, Alexander A. Farahani, Sylvia Signorelli, Maristela L. Onozato, Ruth K. Foreman, Lyn M. Duncan, Donald P. Lawrence, Jochen K. Lennerz, Dora Dias-Santagata, Mai P. Hoang
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 35(12)
Though uncommon in melanoma, gene fusions may have therapeutic implications. Next generation sequencing-based clinical assays, designed to detect relevant gene fusions, mutations, and copy number changes, were performed on 750 melanomas (375 primary
Autor:
Peter M. Sadow, Vânia Nosé, Dora Dias-Santagata, Alexander A. Farahani, Ying-Hsia Chu, Baris Boyraz, William C. Faquin
Publikováno v:
Mod Pathol
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical behavior, histologic characteristics, and molecular landscape are not well understood. We report an institutional series of eleven NTRK-rearranged thyroid carc
Autor:
I-Hsiu Lee, Alexander A. Farahani, Gang Liu, Jochen K. Lennerz, Emma C. E. Wassenaar, Simon R.V. Knott, Wei-Ting Hung, Peter Giunta, Johannes G. Reiter, Onno Kranenburg, Hetal D. Marble, Sebastian Degner, Kamila Naxerova, Shriya Nagpal, Martin S. Taylor, William R. Jeck
Publikováno v:
Nat Genet
Nature genetics
Nature genetics
Genetic diversity among metastases is poorly understood but contains important information about disease evolution at secondary sites. Here we investigate inter- and intra-lesion heterogeneity for two types of metastases that associate with different
Autor:
Dagogo-Jack I; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Manoogian A; Partners Health Specialty Pharmacy, Boston, MA., Jessop N; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Georgantas NZ; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Fintelmann FJ; Harvard Medical School, Boston, MA.; Department of Radiology, Massachusetts General Hospital, Boston, MA., Farahani A; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Digumarthy SR; Harvard Medical School, Boston, MA.; Department of Radiology, Massachusetts General Hospital, Boston, MA., Price MC; Harvard Medical School, Boston, MA.; Department of Radiology, Massachusetts General Hospital, Boston, MA., Folch EE; Harvard Medical School, Boston, MA.; Interventional Pulmonology, Massachusetts General Hospital, Boston, MA., Keyes CM; Harvard Medical School, Boston, MA.; Interventional Pulmonology, Massachusetts General Hospital, Boston, MA., Do A; Massachusetts General Hospital Cancer Center, Boston, MA., Peterson JL; Massachusetts General Hospital Cancer Center, Boston, MA., Mino-Kenudson M; Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Pitman M; Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Rivera M; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Nardi V; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Dias-Santagata D; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Le LP; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Iafrate AJ; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Heist RS; Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Ritterhouse LR; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA., Lennerz JK; Harvard Medical School, Boston, MA.; Center for Integrated Diagnostics, Massachusetts General Hospital, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2023 Sep; Vol. 19 (9), pp. 786-792. Date of Electronic Publication: 2023 Jul 12.
Autor:
Moiso E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts.; Broad Institute of Harvard-MIT, Cambridge, Massachusetts., Farahani A; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Marble HD; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Hendricks A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts., Mildrum S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts., Levine S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts., Lennerz JK; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Garg S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Nov 02; Vol. 12 (11), pp. 2566-2585.
Autor:
Farahani M; 1 Harvard T.H. Chan School of Public Health, Boston, MA, USA., Mulinder H; 2 Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX, USA., Farahani A; 3 Northeastern University, College of Science, Boston, MA, USA., Marlink R; 1 Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Publikováno v:
International journal of STD & AIDS [Int J STD AIDS] 2017 Jun; Vol. 28 (7), pp. 636-650. Date of Electronic Publication: 2016 Feb 10.